METHODS OF SCREENING FOR THERAPEUTIC AGENTS USING NOVEL APOPTOSIS-MODULATING PROTEINS - Patent 0821793

(19)

(11)

EP 0 821 793 A1

(12)

(43)	Date of publication:
	04.02.1998 Bulletin 1998/06

(21)	Application number: 96913062.0

(22)	Date of filing: 19.04.1996

(51)

International Patent Classification (IPC):

A61K 38/ 00^{( . )}
A61P 31/ 12^{( . )}
C07K 14/ 82^{( . )}
G01N 33/ 50^{( . )}
G01N 33/ 68^{( . )}

A61K 45/ 00^{( . )}
C07K 14/ 47^{( . )}
G01N 33/ 15^{( . )}
G01N 33/ 566^{( . )}

(86)	International application number:
	PCT/US1996/005639

(87)	International publication number:
	WO 1996/033416 (24.10.1996 Gazette 1996/47)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

20.04.1995 US 19950426529

(71)	Applicant: LXR BIOTECHNOLOGY INC.
	Richmond, CA 94804-3746 (US)

(72)	Inventors:
	BARR, Philip, J. Orinda, CA 94563 (US) KIEFER, Michael, C. Clayton, CA 94517 (US)

(74)	Representative: Wright, Simon Mark
	J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5LX London WC1R 5LX (GB)

(54)	METHODS OF SCREENING FOR THERAPEUTIC AGENTS USING NOVEL APOPTOSIS-MODULATING PROTEINS